89bio, Inc. - Common Stock (ETNB)

Small-cap benchmark Russell 2000 ETF hits record high after Fed cuts rates, hinting at more cuts. Small caps rally 43% since tariff-driven selloff.

Looking for insights into the US markets one hour before the close of the markets on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Roche is acquiring 89bio for $2.4 billion plus potential milestone payouts, bolstering its pipeline with late-stage MASH drug pegozafermin.

Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.

In today's session, there are notable price gaps in the US markets on Thursday. Take a closer look at the stocks that are gap up and gap down.

The company is now focusing on MASH, a form of fatty liver disease common in people with obesity and type 2 diabetes.

The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

U.S. stock futures advanced on Thursday following Wednesday's mixed moves. Futures of major benchmark indices were higher.

U.S. stock futures trading higher, stocks to watch: Darden, Bullish, Factset. 89bio acquired by Roche. FedEx Q1 earnings expected.

As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

Let's have a look at the gap up and gap down stocks in today's session.

As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.